2019-2023 Physician Office Diagnostic Testing Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts for 300 Tests, Technology Trends, Instrumentation Review

2019-2023 Physician Office Diagnostic Testing Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts for 300 Tests, Technology Trends, Instrumentation Review

  • January 2019 •
  • 970 pages •
  • Report ID: 5372983 •
  • Format: PDF
2019-2023 Physician Office Diagnostic Testing Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts for 300 Tests, Technology Trends, Instrumentation Review

This 970-page report provides a comprehensive analysis of the physician office/group practice diagnostics market, including its dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

This report will help diagnostic reagent and instrument suppliers develop more effective business, RandD and marketing strategies.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis

- Review of the physician office/group practice diagnostics market, including its dynamics, trends, structure, size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts for over 300 chemistry, immunodiagnostic, microbiology, hematology and coagulation procedures, including:

- Routine and Special Chemistry
- Microbiology/Infectious Diseases
- Hematology
- Flow Cytometry
- Coagulation
- Immunoproteins
- Drugs of Abuse
- TDM
- Endocrine Function
- Tumor Markers

Sales and Market Share Analysis

- Sales and market shares of major reagent and instrument suppliers.

Current and Emerging Products

- Analysis of over 130 diagnostic procedures.

- Review of leading chemistry, immunoassay, hematology and coagulation analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.

Technology Review

- Emerging technologies and their applications for physician office/group practice diagnostic testing.

- Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in RandD.

Strategic Recommendations

- Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years.

- Design criteria for POC testing products.

- Alternative business expansion strategies.

- Potential market entry barriers and risks.

Methodology

This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.

Contains 970 pages and 152 tables


Companies Profiled
Competitive Assessments
Abbott
Accriva
Agilent Technologies
Axis-Shield
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data
bioMerieux
Bio-Rad
Cepheid
Chrono-Log
Corgenix
Decode Genetics
Diagnostica Stago
Diamedix
DiaSorin
Eiken Chemical
EKF Diagnostics
Fujirebio
Grifols
Helena Laboratories
Hologic
Horiba
Instrumentation Laboratory/Werfen
Kyowa Medex
Leica Biosystems
Lonza
Nihon Kohden
Ortho-Clinical Diagnostics
Polymedco
Qiagen
Roche
SDIX
Sekisui Diagnostics
Sequenom
Siemens Healthineers
Sienco
Sysmex
Takara Bio
Thermo Fisher
Tosoh
Wako